New pharmaceutical benefits for diabetics
Health Minister Tony Abbott has said patients with diabetes and attention deficit hyperactivity disorder (ADHD) will benefit from treatments to be subsidised through the Pharmaceutical Benefits Scheme (PBS) from 1 July 2007.
An additional form of fast-acting insulin for patients with Type 1 and Type 2 diabetes, insulin glulisine injections, will provide additional choice for both patients and prescribers.
It is expected that around 14,000 diabetics will receive insulin glulisine in its first year on the PBS, rising to around 35,000 in four years. The listing is expected to be cost-neutral.
![Dandenong Mayor [left] stands next to aged care resident and aged care staff member](https://agedcareguide-assets.imgix.net/news/articles/wp/belv__2204.jpg?fm=pjpg&w=370)
![Dandenong Mayor [left] stands next to aged care resident and aged care staff member](https://agedcareguide-assets.imgix.net/news/articles/wp/belv__2204.jpg?fm=pjpg&w=520&format=auto&q=65)
